Ligand validation:1LYK

MAN: alpha-D-mannopyranose

MAN is a Ligand Of Interest in 1LYK designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1LYK_MAN_B_600	58%	10%	0.096	0.873	1.61	2.67	2	3	0	0	100%	0.9167
2E3A_MAN_A_404	98%	28%	0.043	0.968	1.32	1.57	1	3	0	0	100%	0.9167
2E3B_MAN_A_404	98%	31%	0.046	0.97	1.28	1.46	1	2	0	0	100%	0.9167
2E39_MAN_A_404	95%	32%	0.059	0.964	1.27	1.43	1	2	0	0	100%	0.9167
1LY8_MAN_B_700	59%	78%	0.127	0.908	0.46	0.43	-	-	0	0	100%	0.9167
1GAI_MAN_A_480	100%	75%	0.043	0.986	0.45	0.53	-	-	0	0	100%	0.9167
5M03_MAN_A_402	100%	59%	0.034	0.989	0.56	0.99	-	-	0	0	92%	0.9167
1GAH_MAN_A_479	99%	76%	0.05	0.989	0.44	0.5	-	-	0	0	100%	0.9167
1BXO_MAN_A_328	99%	38%	0.05	0.985	1.37	1.08	1	1	0	0	100%	0.9167
7LTB_MAN_B_101	99%	59%	0.053	0.985	0.73	0.85	-	1	0	0	100%	0.9167

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.